Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors

被引：59
|
作者：
Brinkman, K [1 ]
机构：
[1] Onze Lieve Vrouwe Gasthuis, Dept Internal Med, NL-1091 HA Amsterdam, Netherlands
来源：
CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 01期
关键词：
D O I：
10.1086/313921
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：167 / 169
页数：3
相关论文
共 50 条
  • [21] Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase
    Menendez-Arias, Luis
    VIRUS RESEARCH, 2008, 134 (1-2) : 124 - 146
  • [22] Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase
    Painter, GR
    Almond, MR
    Mao, SL
    Liotta, DC
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (10) : 1035 - 1044
  • [23] Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance
    Gallant, JE
    Gerondelis, PZ
    Wainberg, MA
    Shulman, NS
    Haubrich, RH
    St Clair, M
    Lanier, ER
    Hellmann, NS
    Richman, DD
    ANTIVIRAL THERAPY, 2003, 8 (06) : 489 - 506
  • [24] Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors
    Rivero, Antonio
    Mira, Jose A.
    Pineda, Juan A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 342 - 346
  • [25] Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors
    Frerichs, FCP
    Dingemans, KP
    Brinkman, K
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (23): : 1895 - 1896
  • [26] Different effects of nucleoside reverse transcriptase inhibitors on mitochondrial gene expression
    Hoeschele, D.
    Wiertz, M.
    Garcia Moreno, I.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 75 - 75
  • [27] DIAGNOSIS AND MONITORING OF MITOCHONDRIAL TOXICITY INDUCED BY NUCLEOSIDE-ANALOGUE REVERSE-TRANSCRIPTASE INHIBITORS IN HIV-INFECTED PATIENTS UNDERGOING ANTIRETROVIRAL THERAPY
    Tiliscan, Catalin
    Arama, Victoria
    Mihailescu, Raluca
    Streinu-Cercel, Adrian
    Coman, Oana Andreia
    Ion, Daniela
    Ghita, Isabel
    Arama, Stefan Sorin
    FARMACIA, 2011, 59 (04) : 453 - 461
  • [28] Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors
    Pedrol, E
    Ribell, M
    Deig, E
    Villá, MDC
    Miró, O
    Garrabou, G
    Soler, A
    MEDICINA CLINICA, 2005, 125 (06): : 201 - 204
  • [29] The role of nucleoside reverse transcriptase inhibitors usage in the incidence of hyperlactatemia and lactic acidosis in HIV/AIDS patients
    Dragovic, Gordana
    Jevtovic, Djordje
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (04) : 308 - 311
  • [30] Mitochondrial antioxidant status and nucleoside reverse transcriptase inhibitor (NTRI) toxicity.
    Leitner, H
    Goldstein, M
    Min, E
    Gauthier, S
    Day, B
    FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 : S153 - S154
12345